Entering text into the input field will update the search result below

Xencor, Inc. (XNCR) CEO Bassil Dahiyat on Q2 2021 Results - Earnings Call Transcript

Aug. 05, 2021 12:10 AM ETXencor, Inc. (XNCR)
SA Transcripts profile picture
SA Transcripts

Xencor, Inc. (NASDAQ:XNCR) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET

Company Participants

Charles Liles - Head, Corporate Communications and Investor Relations

Bassil Dahiyat - President and Chief Executive Officer

John Desjarlais - Chief Scientific Officer

John Kuch - Chief Financial Officer

Allen Yang - Chief Medical Officer

Conference Call Participants

Ted Tenthoff - Piper Sandler

Jonathan Chang - SVB Leerink

Peter Lawson - Barclays

Arlinda Lee - Canaccord

Kaveri Pohlman - BTIG

Xinyue Lu - RBC Capital Markets

Zhi Shu - Berenberg


Good afternoon, ladies and gentlemen and thank you for standing by and welcome to the Second Quarter 2021 Xencor Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company’s request. Now, I would like to turn the call over to your speaker for today, Charles Liles, Head of Corporate Communications and Investor Relations.

Charles Liles

Thank you and good afternoon. Earlier today, we issued a press release which outlines the topics we plan to discuss today. It’s available at www.xencor.com.

Today on our call, Bassil Dahiyat, President and Chief Executive Officer will review recent business news and pipeline updates; John Desjarlais, Chief Scientific Officer will discuss our cytokine and CD28 programs; and John Kuch, Chief Financial Officer will review financial results. And then we will open up the call for your questions. And Allen Yang, Chief Medical Officer, will join us then.

Before we begin, I would like to remind you that during the course of this conference call, Xencor management may make forward-looking statements, including statements regarding the company’s future financial and operating results, future market conditions, the plans and objectives of management, future operations, the company’s partnering efforts, capital requirements, future product offerings and research and development programs. These forward-looking statements are not historical facts, but rather are based on our current expectations and beliefs and

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.